USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: APELIOTUS TECHNOLOGIES, INC.
City: ATLANTA
State: GA
Zip+4: 30306 3240
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $431,704.00 3
SBIR Phase II $1,118,985.00 1
STTR Phase I $139,832.00 1

Award List:

Diagnostic for Age-Related Macular Degeneration

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: John G. Edwards
Award Amount: $100,000.00
Abstract:
DESCRIPTION (provided by applicant): Apeliotus Technologies proposes to develop a commercial diagnostic for the early detection of age-related macular degeneration (ARMD). It relies on a functional test of dark adaptation kinetics (the transition from being light-adapted to being dark-adapted) that… More

Polymer Stentgraft for Treatment of Cerebral Aneurysms

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Gary L. Loomis
Award Amount: $189,146.00
Abstract:
DESCRIPTION (provided by applicant): Apeliotus Technologies proposes to develop a polymer stentgraft for the treatment of cerebral aneurysms. The stentgraft is formed from coaxial inner and outer tubes of elastomeric polymer, with the gap between the tubes filled by an uncured liquid adhesive. The… More

Diagnostic for Age-Related Macular Degeneration

Award Year / Program / Phase: 2007 / SBIR / Phase II
Agency: HHS
Principal Investigator: John G. Edwards
Award Amount: $1,118,985.00
Abstract:
DESCRIPTION (provided by applicant): This is an SBIR Phase II proposal directed at the continued development of a diagnostic for the early detection of age-related macular degeneration (AMD). It relies on a functional test of dark adaptation kinetics (the transition from being light-adapted to… More

Topical Treatment for Mild Psoriasis

Award Year / Program / Phase: 2007 / STTR / Phase I
Agency: HHS
Research Institution: MEDICAL COLLEGE OF GEORGIA
Principal Investigator: Wendy B. Bollag
Award Amount: $139,832.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): This STTR Phase I proposal is directed at the development of a topical treatment for mild psoriasis. It is based on the recent discovery of a cell signaling module important for the regulation of keratinocyte proliferat ion and differentiation. This signaling… More

AdaptRx: Surrogate Marker for Vision Loss in AMD

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: John G. Edwards
Award Amount: $142,558.00
Abstract:
DESCRIPTION (provided by applicant): Apeliotus Technologies proposes to develop a new clinical trial endpoint for age-related macular degeneration (AMD) based on dark adaptation. A major challenge in attacking AMD is the lack of adequate clinical trial end points. Visual acuity is currently the only… More